CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
NCT: NCT06223893 · RECRUITING
Brief Summary
The CirrhoCare trial is a multi-centre, open label randomised controlled trial in patients with decompensated cirrhosis. The trial aims to investigate the clinical and cost-effectiveness of CirrhoCare digital home monitoring and management with current standard of care in these patients.
Frequently Asked Questions
What is CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis?
CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis is a clinical trial registered under NCT06223893. Current status: RECRUITING.
What is the status of NCT06223893?
The current status of NCT06223893 (CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis) is: RECRUITING.
When did CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis start?
CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis started on 2023-11-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.